35002694|t|Inhibition of Brain GTP Cyclohydrolase I Attenuates 3-Nitropropionic Acid-Induced Striatal Toxicity: Involvement of Mas Receptor/PI3k/Akt/CREB/ BDNF Axis.
35002694|a|GTP cyclohydrolase I (GTPCH I) is the rate-limiting enzyme for tetrahydrobiopterin (BH4) biosynthesis; the latter is an essential factor for iNOS activation that contributes neuronal loss in Huntington's disease (HD). The aim of the study was to investigate the neuroprotective effect of 2,4-diamino-6-hydroxypyrimidine (DAHP), GTPCH I enzyme inhibitor, against neuronal loss in 3-nitropropinic acid (3-NP)-induced HD in rats and to reveal the possible involved mechanisms mediated through PI3K/Akt axis and its correlation to Mas receptor (MasR). Rats received 3-NP (10 mg/kg/day; i.p.) with or without administration of DAHP (0.5 g/kg/day; i.p.) or wortmannin (WM), a PI3K inhibitor, (15 mug/kg/day; i.v.) for 14 days. DAHP improved cognitive, memory, and motor abnormalities induced by 3-NP, as confirmed by striatal histopathological specimens and immunohistochemical examination of GFAP. Moreover, DAHP treatment inhibited GTPCH I activity, resulting in decreased BH4 levels and iNOS activation. Also, DAHP upregulated the protein expression of survival protein; p85/p55 (pY458/199)-PI3K and pS473-Akt that, in turn, boosted the activation of striatal neurotrophic factors and receptor, pS133-CREB, BDNF and pY515-TrKB, which positively affect MasR protein expression and improve mitochondrial dysfunction, as indicated by enhancing both SDH and PGC-1alpha levels. Indeed, DAHP attenuates oxidative stress by increasing SOD activity and Nrf2 expression in addition to reducing neuro-inflammatory status by inhibiting NF-kappaB p65 and TNF-alpha expression. Interestingly, all the previous effects were blocked by co-administration of WM with DAHP. In conclusion, DAHP exerts neuroprotective effect against neuronal loss induced by 3-NP administration via inhibition of GTPCH I and iNOS activity and activation of MasR/PI3K/Akt/CREB/BDNF/TrKB axis besides its antioxidant and anti-inflammatory effect.
35002694	52	73	3-Nitropropionic Acid	Chemical	MESH:C015392
35002694	91	99	Toxicity	Disease	MESH:D064420
35002694	134	137	Akt	Gene	24185
35002694	138	142	CREB	Gene	81646
35002694	144	148	BDNF	Gene	24225
35002694	155	175	GTP cyclohydrolase I	Gene	29244
35002694	177	184	GTPCH I	Gene	29244
35002694	218	237	tetrahydrobiopterin	Chemical	MESH:C003402
35002694	239	242	BH4	Chemical	MESH:C003402
35002694	296	300	iNOS	Gene	24599
35002694	329	342	neuronal loss	Disease	MESH:D009410
35002694	346	366	Huntington's disease	Disease	MESH:D006816
35002694	368	370	HD	Disease	MESH:D006816
35002694	443	474	2,4-diamino-6-hydroxypyrimidine	Chemical	MESH:C017202
35002694	476	480	DAHP	Chemical	MESH:C017202
35002694	483	490	GTPCH I	Gene	29244
35002694	517	530	neuronal loss	Disease	MESH:D009410
35002694	534	554	3-nitropropinic acid	Chemical	-
35002694	556	560	3-NP	Chemical	-
35002694	570	572	HD	Disease	MESH:D006816
35002694	576	580	rats	Species	10116
35002694	650	653	Akt	Gene	24185
35002694	703	707	Rats	Species	10116
35002694	717	721	3-NP	Chemical	-
35002694	777	781	DAHP	Chemical	MESH:C017202
35002694	806	816	wortmannin	Chemical	MESH:D000077191
35002694	818	820	WM	Chemical	MESH:D000077191
35002694	876	880	DAHP	Chemical	MESH:C017202
35002694	890	932	cognitive, memory, and motor abnormalities	Disease	MESH:D003072
35002694	944	948	3-NP	Chemical	-
35002694	1042	1046	GFAP	Gene	24387
35002694	1058	1062	DAHP	Chemical	MESH:C017202
35002694	1083	1090	GTPCH I	Gene	29244
35002694	1124	1127	BH4	Chemical	MESH:C003402
35002694	1139	1143	iNOS	Gene	24599
35002694	1162	1166	DAHP	Chemical	MESH:C017202
35002694	1227	1230	p55	Gene	25625
35002694	1258	1261	Akt	Gene	24185
35002694	1353	1357	CREB	Gene	81646
35002694	1359	1363	BDNF	Gene	24225
35002694	1374	1378	TrKB	Gene	25054
35002694	1440	1465	mitochondrial dysfunction	Disease	MESH:D028361
35002694	1506	1516	PGC-1alpha	Gene	83516
35002694	1533	1537	DAHP	Chemical	MESH:C017202
35002694	1597	1601	Nrf2	Gene	83619
35002694	1637	1655	neuro-inflammatory	Disease	MESH:C536203
35002694	1695	1704	TNF-alpha	Gene	24835
35002694	1794	1796	WM	Chemical	MESH:D000077191
35002694	1802	1806	DAHP	Chemical	MESH:C017202
35002694	1823	1827	DAHP	Chemical	MESH:C017202
35002694	1866	1879	neuronal loss	Disease	MESH:D009410
35002694	1891	1895	3-NP	Chemical	-
35002694	1929	1936	GTPCH I	Gene	29244
35002694	1941	1945	iNOS	Gene	24599
35002694	1983	1986	Akt	Gene	24185
35002694	1987	1991	CREB	Gene	81646
35002694	1992	1996	BDNF	Gene	24225
35002694	1997	2001	TrKB	Gene	25054
35002694	2040	2052	inflammatory	Disease	MESH:D007249
35002694	Negative_Correlation	MESH:C017202	24387
35002694	Positive_Correlation	MESH:C017202	24225
35002694	Association	MESH:D028361	25054
35002694	Positive_Correlation	MESH:C017202	81646
35002694	Positive_Correlation	MESH:C017202	MESH:D028361
35002694	Negative_Correlation	MESH:C017202	24835
35002694	Positive_Correlation	24599	29244
35002694	Association	MESH:D009410	24599
35002694	Positive_Correlation	MESH:C017202	83516
35002694	Association	MESH:C003402	29244
35002694	Negative_Correlation	MESH:C017202	MESH:D003072
35002694	Association	MESH:D006816	29244
35002694	Positive_Correlation	MESH:C015392	MESH:D064420
35002694	Positive_Correlation	MESH:C017202	24599
35002694	Association	25054	83516
35002694	Negative_Correlation	MESH:D000077191	24835
35002694	Positive_Correlation	MESH:C017202	24185
35002694	Negative_Correlation	MESH:C017202	MESH:C536203
35002694	Negative_Correlation	MESH:C017202	MESH:D009410
35002694	Negative_Correlation	MESH:C003402	MESH:C017202
35002694	Negative_Correlation	MESH:C017202	29244
35002694	Positive_Correlation	MESH:C017202	25054
35002694	Association	MESH:D028361	83516
35002694	Positive_Correlation	MESH:C017202	83619
35002694	Association	MESH:D028361	24225
35002694	Positive_Correlation	MESH:C017202	25625
35002694	Association	MESH:D009410	29244
35002694	Association	MESH:C536203	24835

